Status:

COMPLETED

Activated Factor Seven in Traumatic Retro Peritoneal Hematoma

Lead Sponsor:

King Abdul Aziz Specialist Hospital

Conditions:

Traumatic Bleeding

Eligibility:

All Genders

18-65 years

Brief Summary

80 patients with traumatic retro-peritoneal hematoma allocated into two groups 40 patients each. Patients of Group A received aminocaproic acid while patients of group B received aFVII. Number of pack...

Detailed Description

80 patients admitted to King Abdul-Aziz Specialist Hospital in Taif, KSA between May 2017 and December 2019 with polytrauma and severe retroperitoneal bleeding diagnosed by abdominal computerized tomo...

Eligibility Criteria

Inclusion

  • severe bleeding

Exclusion

  • post arrest

Key Trial Info

Start Date :

May 5 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 30 2019

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04424563

Start Date

May 5 2017

End Date

December 30 2019

Last Update

June 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

King abd el Aziz specialist hospital

Ta'if, Saudi Arabia, 21944

Activated Factor Seven in Traumatic Retro Peritoneal Hematoma | DecenTrialz